Dr. Haraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-0610
Summary
- Dr. Daniel Haraf is a radiation oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center and University of Illinois Hospital & Health Sciences System. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 35 years. He is experienced in lung cancer, neck pain, and head and neck radiation oncology.
Education & Training
- University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1985 - 1988
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
Certifications & Licensure
- IL State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing Start of enrollment: 2018 Jan 22
Publications & Presentations
PubMed
- 73 citationsAspiration in Chemoradiated Patients With Head and Neck CancerAlexander Langerman, Ellen MacCracken, Kristen Kasza, Daniel J. Haraf, Everett E. Vokes
Archives of Otolaryngology--Head & Neck Surgery. 2007-12-01 - 452 citationsThe performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validityMarcy A. List, Linda L. D'Antonio, David Cella, Amy K. Siston, Patricia Mumby
Cancer. 1996-06-01 - 22 citationsConcurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.Aaron W. Pederson, Joseph K. Salama, Mary Ellen Witt, Kerstin M. Stenson, Elizabeth A. Blair
American Journal of Clinical Oncology. 2011-08-01
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Other
- Paranasal sinus cancerHaraf DJ, Stenson KM
http://www.uptodate.com/contents/paranasal-sinus-cancer
UpToDate, Wolters Kluwer Health - 2012-04-06 - Reirradiation for locally recurrent head and neck cancerHaraf DJ, Salama JK, Milano MT
http://www.uptodate.com/contents/reirradiation-for-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-07-20 - Treatment of locally recurrent head and neck cancerHaraf DJ, Milano MT, Chmura SJ
http://www.uptodate.com/contents/treatment-of-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-08-29
Press Mentions
- First He Survived Cancer – Now He Studies ItNovember 14th, 2022
Grant Support
- Core--Biostatistics, Data Management And ClinicalNational Institute Of Dental &Craniofacial Research1996–2001
- Core--Clinical Trial Protocol Review And Monitoring SystemNational Cancer Institute1996–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: